Ignacio Wistuba Selected Research

Adjuvant Chemotherapy

1/2015	Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.
8/2004	[Atypical presentation of a colorectal carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ignacio Wistuba Research Topics

Disease

58	Neoplasms (Cancer) 05/2022 - 08/2004
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2006
17	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2010
11	Adenocarcinoma of Lung 05/2022 - 04/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 04/2017
5	Adenocarcinoma 01/2015 - 04/2006
4	Carcinoma (Carcinomatosis) 01/2022 - 04/2007
3	Neoplasm Metastasis (Metastasis) 05/2022 - 10/2010
3	Inflammation (Inflammations) 07/2021 - 04/2006
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 02/2011
3	Malignant Mesothelioma 06/2014 - 10/2009
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 11/2009
2	Mesothelioma 06/2014 - 04/2009
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2013 - 02/2011
2	Carcinogenesis 04/2008 - 04/2006
1	Cholangiocarcinoma 01/2022
1	Febrile Neutropenia 11/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Glioma (Gliomas) 10/2018
1	Hyperplasia 10/2017
1	Ovarian Neoplasms (Ovarian Cancer) 04/2017

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2012
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
6	Tyrosine Kinase InhibitorsIBA 03/2018 - 08/2010
6	ErbB Receptors (EGF Receptor)IBA 11/2017 - 03/2006
5	DNA (Deoxyribonucleic Acid)IBA 05/2019 - 12/2008
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	Biological ProductsIBA 10/2018 - 07/2004
3	EnzymesIBA 05/2022 - 07/2021
3	B7-H1 AntigenIBA 01/2022 - 10/2018
3	AntibodiesIBA 01/2022 - 01/2019
3	Pemetrexed (MTA)FDA Link 01/2022 - 02/2011
3	NivolumabIBA 01/2022 - 01/2019
3	Circulating Tumor DNAIBA 10/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2021 - 01/2015
3	theasinensin AIBA 01/2021 - 09/2015
3	ParaffinIBA 01/2021 - 01/2015
3	Messenger RNA (mRNA)IBA 10/2019 - 09/2014
3	Phosphotransferases (Kinase)IBA 11/2017 - 05/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 11/2012
3	Sorafenib (BAY 43-9006)FDA Link 12/2013 - 11/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009 - 07/2007
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022 - 11/2021
2	liquid crystal polymerIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Phenobarbital (Luminal)FDA Link 07/2021 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2019 - 09/2015
2	pyrimidineIBA 05/2019 - 01/2017
2	Thyroid Nuclear Factor 1IBA 01/2019 - 05/2013
2	LigandsIBA 10/2017 - 04/2006
2	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 05/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2017
2	MucinsIBA 05/2013 - 02/2011
2	vandetanib (ZD6474)IBA 05/2013 - 11/2012
2	Colloids (Colloid)IBA 05/2013 - 02/2011
2	Bexarotene (LGD1069)FDA Link 05/2013 - 11/2012
2	Dasatinib (BMS 354825)FDA Link 05/2012 - 10/2010
1	KynurenineIBA 05/2022
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	kynureninaseIBA 05/2022
1	Folic Acid AntagonistsIBA 01/2022
1	urelumabIBA 01/2022
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	purineIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	Interferon Type IIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	Lipase (Acid Lipase)FDA Link 11/2020
1	pembrolizumabIBA 01/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	VaccinesIBA 01/2019
1	atezolizumabIBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2018
1	Mucin-3IBA 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	VimentinIBA 01/2018
1	Hormones (Hormone)IBA 11/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2017
1	HhAntag691IBA 11/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2017

Therapy/Procedure

18	Therapeutics 05/2022 - 04/2009
3	Immunotherapy 01/2022 - 01/2021
3	Neoadjuvant Therapy 11/2020 - 01/2020
2	Adjuvant Chemotherapy 01/2015 - 08/2004
1	Precision Medicine 10/2021
1	Aftercare (After-Treatment) 10/2018